Taringa, Australia

Doug Bergman

This inventor holds 1 USPTO granted patent. Top assignee: The University of Queensland. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doug Bergman. Retrieved from https://idiyas.com/inventor/doug-bergman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Doug Bergman: Innovator in HIV Protease Inhibitors

Introduction

Doug Bergman is a notable inventor based in Taringa, Australia. He has made significant contributions to the field of medical research, particularly in the development of HIV protease inhibitors. His work has the potential to impact the treatment of HIV, showcasing his dedication to advancing healthcare.

Latest Patents

Doug Bergman holds a patent related to HIV protease inhibitors. This patent represents his innovative approach to tackling one of the most challenging aspects of HIV treatment. With 1 patent to his name, he has established himself as a key player in this important area of research.

Career Highlights

Bergman is affiliated with The University of Queensland, where he continues to engage in groundbreaking research. His position at this esteemed institution allows him to collaborate with other experts in the field and contribute to the advancement of medical science.

Collaborations

Throughout his career, Doug has worked alongside notable colleagues such as Ross Brinkworth and Peter Hunt. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Doug Bergman is a dedicated inventor whose work on HIV protease inhibitors exemplifies his commitment to improving healthcare. His contributions to the field are invaluable, and his ongoing research promises to yield further advancements in the treatment of HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…